2014
DOI: 10.1007/s00125-014-3383-9
|View full text |Cite
|
Sign up to set email alerts
|

Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up

Abstract: Aims/hypothesis Insulin resistance is commonly proposed as a precursor to both type 2 diabetes and cardiovascular disease (CVD), yet few studies have directly compared insulin resistance with both outcomes simultaneously and determined whether associations with each outcome differ in strength or are comparable. We assessed the association of fasting insulin and HOMA-IR with incident CVD and diabetes in older people. Methods In the long-term follow-up of the Prospective Study of Pravastatin in the Elderly at Ri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
21
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(25 citation statements)
references
References 24 publications
4
21
0
Order By: Relevance
“…Information on the associations between fasting insulin and HOMA-IR with incident type 2 diabetes is scarce. In the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) study, HOMA-IR was more strongly associated with incident type 2 diabetes than fasting insulin [ 25 ], which corresponds to the observations in our study. Moreover, in the PROSPER study and the San Antonio Heart Study, fasting insulin was significantly associated with the risk of developing type 2 diabetes after adjustment for confounders, while in our study the association between fasting insulin and incident type 2 diabetes was no longer statistically significant after adjusting for metabolic and lifestyle risk factors [ 25 , 26 ].…”
Section: Discussionsupporting
confidence: 88%
“…Information on the associations between fasting insulin and HOMA-IR with incident type 2 diabetes is scarce. In the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) study, HOMA-IR was more strongly associated with incident type 2 diabetes than fasting insulin [ 25 ], which corresponds to the observations in our study. Moreover, in the PROSPER study and the San Antonio Heart Study, fasting insulin was significantly associated with the risk of developing type 2 diabetes after adjustment for confounders, while in our study the association between fasting insulin and incident type 2 diabetes was no longer statistically significant after adjusting for metabolic and lifestyle risk factors [ 25 , 26 ].…”
Section: Discussionsupporting
confidence: 88%
“…Differences in fasting glucose of 0.5 mmol/L (~5 times higher than found in the trials with higher PUFA intake in our meta-analysis) are associated with a 10% increased risk of coronary heart disease35 and a two to threefold increased risk of type 2 diabetes 36 37. Fasting insulin and HOMA-IR are related to diabetes risk, per 0.5 unit difference in HOMA-IR (~4 times the current observations), risk for diabetes increases with 20%–80% 36 38…”
Section: Discussionsupporting
confidence: 48%
“…Insulin resistance, assessed by HOMA-IR, is a direct and important predictor of diabetes (Welsh et al 2014). In the present study, only HIIT improved insulin resistance and these findings were not confounded by changes in body weight or adiposity.…”
Section: Discussionmentioning
confidence: 99%